Compare ERII & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ERII | NPCE |
|---|---|---|
| Founded | 1992 | 1997 |
| Country | United States | United States |
| Employees | N/A | 220 |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 595.9M | 536.6M |
| IPO Year | 2008 | 2021 |
| Metric | ERII | NPCE |
|---|---|---|
| Price | $8.07 | $15.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $17.07 | ★ $18.33 |
| AVG Volume (30 Days) | ★ 1.3M | 184.1K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 5.00 | ★ 29.03 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $134,987,000.00 | $99,986,000.00 |
| Revenue This Year | N/A | $0.90 |
| Revenue Next Year | $20.55 | $24.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $7.94 | $7.56 |
| 52 Week High | $18.31 | $19.60 |
| Indicator | ERII | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 36.38 | 44.43 |
| Support Level | N/A | $15.40 |
| Resistance Level | $11.58 | $17.37 |
| Average True Range (ATR) | 0.35 | 0.81 |
| MACD | 0.01 | -0.12 |
| Stochastic Oscillator | 9.06 | 14.91 |
Energy Recovery Inc designs and manufactures energy-saving technologies. The firm uses its proprietary pressure exchanger technology to help customers in multiple industries improve their operations and lower their emissions. Using its proprietary technology, it offers energy recovery devices, including pressure exchangers, pumps, and turbochargers, mainly used for seawater desalination and wastewater treatment. Additionally, the company is involved in the development of emerging technologies, such as the PX G1300 used in industrial and commercial refrigeration applications. The firm's reportable operating segments are: Water, which generates maximum revenue, and Emerging Technologies. Geographically, it generates maximum revenue from the Middle East, and the rest from other markets.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.